Merck & Co., Inc.

Insider Reports History

Location
Rahway, NJ
Signature
/s/ Kelly Grez, Corporate Secretary
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Merck & Co., Inc.:

Company Role Class Num Shares Value Price $ Report Date Ownership
Personalis, Inc. 10%+ Owner Common Stock, $0.0001 par value per share 14,044,943 $53,651,682 $3.82 19 Dec 2024 Indirect
Harpoon Therapeutics, Inc. 10%+ Owner Common Stock, par value $0.0001 1,000 $23,000 $23.00 11 Mar 2024 Indirect
Organon & Co. 10%+ Owner Common Stock 0 $21.53 02 Jun 2021 Direct

Insider Reports Filed by Merck & Co., Inc.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
PSNL Personalis, Inc. 19 Dec 2024 0 $0 3 10%+ Owner 23 Dec 2024, 06:00
/report/000095017024029165-merck-co-inc-2024-03-11 Harpoon Therapeutics, Inc. 11 Mar 2024 1 +$492,135,715 4 10%+ Owner 11 Mar 2024, 15:27
/report/000095017024005090-merck-co-inc-2024-01-07 Harpoon Therapeutics, Inc. 07 Jan 2024 0 $0 3 10%+ Owner 17 Jan 2024, 17:52
OGN Organon & Co. 02 Jun 2021 1 $0 4 10%+ Owner 04 Jun 2021, 16:46
OGN Organon & Co. 07 May 2021 0 $0 3 10%+ Owner 07 May 2021, 17:02